Serum paraoxonase and arylesterase activities in patients with chronic otitis media

References

• Baysal E, Aksoy N, Kara F, Taysi S, Taşkın A, Bilinç H, et al. Oxidative stress in chronic otitis media. Eur Arch Otorhinolaryngol 2013;270(4):1203–8. doi: 10.1007/s00405-012-2070-z
   PubMed Web of Science ®Google Scholar
• Karlidağ T, Ilhan N, Kaygusuz I, Keleş E, Yalçin S. Comparison of free radicals and antioxidant enzymes in chronic otitis media with and without tympanosclerosis. Laryngoscope 2004;114(1):85–9. doi: 10.1097/00005537-200401000-00014
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44–84. doi: 10.1016/j.biocel.2006.07.001
   PubMed Web of Science ®Google Scholar
• Serafini M, Del Rio D. Understanding the association between dietary antioxidants, redox status and disease: is the Total Antioxidant Capacity the right tool? Redox Rep 2004;9(3):145–52. doi: 10.1179/135100004225004814
   PubMed Web of Science ®Google Scholar
• Doğruer ZN, Unal M, Eskandari G, Pata YS, Akbaş Y, Cevik T, et al. Malondialdehyde and antioxidant enzymes in children with obstructive adenotonsillar hypertrophy. Clin Biochem 2004;37(8):718–21. doi: 10.1016/j.clinbiochem.2004.01.004
   PubMed Web of Science ®Google Scholar
• Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721–4. doi: 10.1016/S0140-6736(94)92211-X
   PubMed Web of Science ®Google Scholar
• Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN . Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high-density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 1998;423:57–60. doi: 10.1016/S0014-5793(98)00064-7
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581–90. doi: 10.1172/JCI1649
   PubMed Web of Science ®Google Scholar
• Kotur-Stevuljevic J, Spasic S, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Stefanovic A, Vujovic A, et al. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients. Clin Biochem 2008;41(13):1067–73. doi: 10.1016/j.clinbiochem.2008.06.009
   PubMed Web of Science ®Google Scholar
• Selek S, Cosar N, Kocyigit A, Erel O, Aksoy N, Gencer M, et al. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Clin Biochem 2008;41(3):140–4. doi: 10.1016/j.clinbiochem.2007.11.018
   PubMed Web of Science ®Google Scholar
• Erdem FH, Karatay S, Yildirim K, Kiziltunc A. Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients. Clinics (Sao Paulo) 2010;65(2):175–9. doi: 10.1590/S1807-59322010000200009
   PubMed Web of Science ®Google Scholar
• Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35:1126–38.
   PubMed Web of Science ®Google Scholar
• Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C. 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992;30:391–5.
   PubMedGoogle Scholar
• Nourooz Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999;300:58–62. doi: 10.1016/S0076-6879(99)00113-5
   PubMed Web of Science ®Google Scholar
• Semaan MT, Megerian CA. The pathophysiology of cholesteatoma. Otolaryngol Clin North Am 2006;39(6):1143–59. doi: 10.1016/j.otc.2006.08.003
   PubMed Web of Science ®Google Scholar
• Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47–95. doi: 10.1152/physrev.00018.2001
   PubMed Web of Science ®Google Scholar
• Döner F, Delibaş N, Dogru H, Yariktaş M, Demirci M. The role of free oxygen radicals in experimental otitis media. J Basic Clin Physiol Pharmacol 2002;13(1):33–40. doi: 10.1515/JBCPP.2002.13.1.33
   PubMedGoogle Scholar
• Yilmaz T, Kocan EG, Besler HT, Yilmaz G, Gursel B. The role of oxidants and antioxidants in otitis media with effusion in children. Otolaryngol Head Neck Surg 2004;131(6):797–803. doi: 10.1016/j.otohns.2004.07.001
   PubMed Web of Science ®Google Scholar
• Taysi S, Kocer I, Memisogullari R, Kiziltunc A. Serum oxidant/antioxidant status in patients with Behçet's disease. Ann Clin Lab Sci 2002;32(4):377–82.
   PubMed Web of Science ®Google Scholar
• Henson PM, Johnston RB. Tissue injury and inflammation. J Clin Int 1987;79:669–74.
   Google Scholar
• Gutteridge JMC. Free radicals in disease processes: a complication of cause and consequence. Free Radic Res Commun 1993;19:141–58. doi: 10.3109/10715769309111598
   PubMed Web of Science ®Google Scholar
• Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M. Auto-oxidative damage in Behçet's disease – endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982;49(1):247–55.
   PubMed Web of Science ®Google Scholar
• Koc S, Aksoy N, Bilinc H, Duygu F, Uysal IO, Ekinci A. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis. Int J Pediatr Otorhinolaryngol 2011;75(11):1364–7. doi: 10.1016/j.ijporl.2011.07.017
   PubMed Web of Science ®Google Scholar
• Duygu F, Tekin Koruk S, Aksoy N. Serum paraoxonase and arylesterase activities in various forms of hepatitis B virus infection. J Clin Lab Anal 2011;25(5):311–6. doi: 10.1002/jcla.20473
   PubMed Web of Science ®Google Scholar
• Chole RA, Faddis BT. Evidence for microbial biofilms in cholesteatomas. Arch Otolaryngol Head Neck Surg 2002;128(10):1129–33. doi: 10.1001/archotol.128.10.1129
   PubMedGoogle Scholar
• Jung JY, Pashia ME, Nishimoto SY, Faddis BT, Chole RA. A possible role for nitric oxide in osteoclastogenesis associated with cholesteatoma. Otol Neurotol 2004;25(5):661–8. doi: 10.1097/00129492-200409000-00003
   PubMed Web of Science ®Google Scholar
• Yilmaz A, Uslu C, Akyuz M. Nitric oxide synthase activity and nitric oxide level in erythrocytes of guinea pigs with experimental otitis media with effusion. Cell Biochem Funct 2006;24(5):471–3. doi: 10.1002/cbf.1299
   PubMed Web of Science ®Google Scholar
• Takoudes TG, Haddad JJr Evidence of oxygen free radical damage in human otitis media. Otolaryngol Head Neck Surg 1999;120(5):638–42. doi: 10.1053/hn.1999.v120.a91768
   PubMed Web of Science ®Google Scholar
• Shigemi H, Egashira T, Kurono Y, Mogi G. Role of superoxide dismutase in otitis media with effusion. Ann Otol Rhinol Laryngol 1998;107(4):327–31. doi: 10.1177/000348949810700411
   PubMed Web of Science ®Google Scholar
• Aktan B, Gundogdu C, Ucuncu H, Unal B, Sütbeyaz Y, Altas S. Anti-inflammatory effect of erythromycin on histamine-induced otitis media with effusion in guinea pigs. J Laryngol Otol 2004;118(2):97–101. doi: 10.1258/002221504772784522
   PubMed Web of Science ®Google Scholar
• Soyoral YU, Aslan M, Emre H, Begenik H, Erdur FM, Turkel A. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome. Atherosclerosis 2011;218(1):243–6. doi: 10.1016/j.atherosclerosis.2011.05.037
   PubMed Web of Science ®Google Scholar
• Aslan M, Nazligul Y, Horoz M, Bolukbas C, Bolukbas FF, Gur M, et al. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects. Atherosclerosis 2008;196(1):270–4. doi: 10.1016/j.atherosclerosis.2006.10.024
   PubMed Web of Science ®Google Scholar
• Karakucuk S, Baskol G, Oner AO, Baskol M, Mirza E, Ustdal M. Serum paraoxonase activity is decreased in the active stage of Behcet's disease. Br J Ophthalmol 2004;88:1256–8. doi: 10.1136/bjo.2004.043398
   PubMed Web of Science ®Google Scholar
• Karahocagil MK, Aslan M, Ceylan MR, Cıkman A, Sunnetcioglu M, Kucukoglu ME, et al. Serum myeloperoxidase activity and oxidative stress in patients with acute brucellosis. Clin Biochem 2012;45(10–11):733–6. doi: 10.1016/j.clinbiochem.2012.03.017
   PubMed Web of Science ®Google Scholar
• Jayakumari N, Thejaseebai G. High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease. J Clin Biochem Nutr 2009;45(3):278–84. doi: 10.3164/jcbn.08-255
   PubMed Web of Science ®Google Scholar
• Murakami H, Tanabe J, Tamasawa N, Matsumura K, Yamashita M, Matsuki K, et al. Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes. Diabetes Res Clin Pract 2013;99(1):30–8. doi: 10.1016/j.diabres.2012.10.022
   PubMed Web of Science ®Google Scholar
• Mohamadin AM, Habib FA, Elahi TF. Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome. Pathophysiology 2010;17(3):189–96. doi: 10.1016/j.pathophys.2009.11.004
   PubMedGoogle Scholar
• Camps J, Pujol I, Ballester F, Joven J, Simó JM. Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria. Antimicrob Agents Chemother 2011;55(4):1325–31. doi: 10.1128/AAC.01502-10
   PubMed Web of Science ®Google Scholar